Free Trial
NYSEARCA:REVS

Columbia Research Enhanced Value ETF (REVS) Price, Holdings, & News

$25.40
+0.01 (+0.04%)
(As of 12:50 PM ET)

About Columbia Research Enhanced Value ETF (NYSEARCA:REVS)

Key Stats

Today's Range
$25.33
$25.52
50-Day Range
$24.40
$25.98
52-Week Range
$20.00
$26.01
Volume
3,912 shs
Average Volume
13,423 shs
Market Capitalization
$45.72 million
Assets Under Management
$66.01 million
Dividend Yield
1.89%
Net Expense Ratio
0.19%
Aggregate Rating
Moderate Buy

ETF Overview

The Columbia Research Enhanced Value ETF (REVS) is an exchange-traded fund that mostly invests in large cap equity. The fund tracks an index of US stocks pulled from the Russell 1000 Value Index. REVS index uses multifactor selection and market cap weighting. REVS was launched on Sep 25, 2019 and is managed by Columbia.

Columbia Research Enhanced Value ETF Expenses

TypeREVSLarge Cap ETFsEquity ETFsNYSEARCA ETFsAll ETFs
Management Fee0.19%0.57%0.55%0.51%0.52%
Other Expenses0.00%0.31%0.49%0.58%0.53%
Total Expense0.19%0.65%0.71%0.73%0.71%
Fee Waiver0.00%-0.26%-0.52%-0.67%-0.57%
Net Expense0.19%0.62%0.61%0.58%0.59%
Receive REVS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Columbia Research Enhanced Value ETF and its competitors with MarketBeat's FREE daily newsletter.

REVS ETF News Headlines

REVS Columbia Research Enhanced Value ETF
The centerpiece of Trump’s crypto’s masterplan …
Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin conference in Nashville … Where he told an adoring crowd that the U.S. would become … “The crypto capital of the planet and the Bitcoin superpower of the world.”
Columbia Thermostat A CTFAX
See More Headlines

REVS ETF - Frequently Asked Questions

Columbia Research Enhanced Value ETF's stock was trading at $21.65 on January 1st, 2024. Since then, REVS shares have increased by 17.3% and is now trading at $25.40.
View the best growth stocks for 2024 here
.

Top institutional investors of Columbia Research Enhanced Value ETF include Wealth Enhancement Advisory Services LLC (2.15%).

Shares of REVS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Columbia Research Enhanced Value ETF investors own include The GEO Group (GEO), Global X SuperDividend REIT ETF (SRET), BlackRock Capital Investment (BKCC), British American Tobacco (BTI), Energy Transfer (ET), International Business Machines (IBM) and Annaly Capital Management (NLY).

Fund Details

Issuer
Columbia
Fund Name
Columbia Research Enhanced Value ETF
Tax Classification
Regulated Investment Company
Current Symbol
NYSEARCA:REVS
Inception Date
9/25/2019
Fund Manager
Christopher Lo, Jason Wang
Web
N/A
Phone
N/A

Fund Focus

Asset Class
Equity
Benchmark
Beta Advantage Research Enhanced U.S. Value Index
Category
Size and Style
Focus
Large Cap
Development Level
Developed Markets
Region
North America
Number of Holdings
313

Fund Statistics

Assets Under Management
$66.01 million
Average Daily Volume
$0.00
Discount/Premium
0.00%

Administrator, Advisor and Custodian

Administrator
The Bank of New York Mellon Corporation
Advisor
Columbia Management Investment Advisers, LLC
Custodian
The Bank of New York Mellon Corporation
Distributor
ALPS Distributors, Inc.
Transfer Agent
The Bank of New York Mellon Corporation
Trustee
N/A
Lead Market Maker
Jane Street

Options

Optionable
N/A
Short Interest
16,700 shs

Miscellaneous

Beta
0.76
Creation Unit
50,000
Creation Fee
$500.00
(Almost)  Everything You Need To Know About The EV Market Cover

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

Top 10 REVS Holdings

REVS Sector Exposure

REVS Industry Exposure


This page (NYSEARCA:REVS) was last updated on 11/4/2024 by MarketBeat.com Staff
From Our Partners